How is an endoscopic ultrasound (EUS)-guided coil embolization performed, including patient preparation, coil selection and deployment, and post‑procedure care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

EUS-Guided Coil Embolization Procedure

EUS-guided coil embolization for gastric varices is performed by intubating the patient in left lateral decubitus position, instilling 100-200 mL of water into the gastric fundus for vessel delineation, accessing the target vessel with a 19- or 22-gauge needle under EUS guidance, deploying 1-3 coils sequentially while monitoring Doppler flow reduction, and optionally injecting adjunctive cyanoacrylate when near-absent flow is achieved. 1

Patient Preparation

  • Intubation and positioning: Patient is intubated and placed in left lateral decubitus position 1
  • Water instillation: 100-200 cm³ of water is instilled through the echoendoscope and retained in the gastric fundus to enhance visualization of intramural vessels (gastric varices) and distinguish them from extramural collaterals 1
  • Vessel mapping: Use EUS with Doppler to identify the gastric varix and trace perforator veins by following extramural vessels across the muscularis propria into the intramural varix 1

Coil Selection and Deployment

Coil Specifications

  • Type: Nester or MReye embolization coils (Cook Medical) are most commonly used 1
  • Construction: Soft platinum wires with spaced synthetic fibers designed to initiate thrombus formation 1
  • Number: Typically 1-3 coils per session 1

Deployment Technique

  • Needle selection: Use 19-gauge or 22-gauge fine needle aspiration needle 1
  • Approach: Access via transesophageal or transgastric route depending on varix location 1
  • Target selection: Either the varix itself or the perforator vein(s) can be targeted, though no definitive data exists on which is superior 1. Recent evidence suggests targeting the feeder vessel when discernible may require fewer coils and less glue with lower reintervention rates 2
  • Sequential placement: Deploy coils one at a time into the targeted vessel 1
  • Real-time monitoring: Use Doppler interrogation during coil placement to guide the number of coils required 1
  • Fluoroscopy: Optional but helpful, particularly early in the learning curve; not required for experienced operators 1

Adjunctive Therapy

  • Cyanoacrylate injection: When significant reduction or near-absent Doppler flow is achieved, inject cyanoacrylate glue as adjunctive therapy 1
  • Combination therapy superiority: Meta-analyses show EUS-guided combination therapy (coil + glue) achieves 96-98% hemostasis with only 5% recurrence rates, significantly better than monotherapy 1
  • Alternative agents: Absorbable gelatin sponge (GELFOAM) can be used instead of cyanoacrylate with similar low rebleeding rates 1, 3

Post-Procedure Care

Immediate Assessment

  • Doppler confirmation: Verify cessation or significant reduction of flow in treated vessel 1, 4
  • Endoscopic verification: Confirm hemostasis endoscopically 4
  • Hemoglobin monitoring: Track hemoglobin levels for stabilization 4

Follow-Up

  • Repeat endoscopy: Perform follow-up endoscopy to assess for varix shrinkage and absence of active bleeding 4
  • Additional sessions: Repeat treatment of other varices can be performed as required 1
  • Surveillance interval: Follow-up EUS at 12 weeks can assess lumen obliteration 1

Clinical Outcomes

The evidence strongly supports EUS-guided coil therapy over direct endoscopic injection (DEI), with technical success rates of approximately 99%, control of bleeding in 96-100% of cases, rebleeding rates of 0-16%, and adverse event rates of 0-7% 1. Meta-analysis demonstrates gastric variceal obliteration of 84% with EUS-guided therapy versus 63% with DEI (P = .02) 1.

Critical Considerations

Training Requirements

  • The multiple steps involved require adequate training of nurses and technicians 1
  • Endosonographers should be trained in interventional EUS and operate as part of a multidisciplinary team 1

Technical Nuances

  • Heterogeneous technique: Current practice varies regarding target vessel choice, coil size/number, and injectate type—consensus technique development would be beneficial 1
  • Feeder vessel targeting: When the feeder vessel is clearly discernible, targeting it directly rather than the submucosal variceal component may reduce coil/glue requirements and reintervention rates 2

Safety Profile

  • Adverse event rates range from 0-7% in most series 1
  • The technique is particularly valuable in patients with contraindications to cyanoacrylate (e.g., patent foramen ovale) where coils can be used as monotherapy 4, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.